Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
535
-
Total 13F shares, excl. options
-
172M
-
Shares change
-
-3.46M
-
Total reported value, excl. options
-
$14.9B
-
Value change
-
-$352M
-
Put/Call ratio
-
0.9
-
Number of buys
-
246
-
Number of sells
-
-241
-
Price
-
$86.68
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2023
655 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2023.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 535 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 172M shares
of 194M outstanding shares and own 89% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (18.4M shares), VANGUARD GROUP INC (17.7M shares), Dodge & Cox (14.3M shares), BlackRock Inc. (14M shares), Capital Research Global Investors (6.76M shares), STATE STREET CORP (5.95M shares), AMERIPRISE FINANCIAL INC (4.89M shares), VIKING GLOBAL INVESTORS LP (4.16M shares), Avoro Capital Advisors LLC (4M shares), and BAKER BROS. ADVISORS LP (3.81M shares).
This table shows the top 535 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.